The Asia Pacific vaccine market was valued at USD 4.92 Billion in 2025, driven by the growing incidence of infectious diseases, rising innovations in vaccine technology, and increasing immunization programs in the region. The market is further expected to grow in the forecast period of 2026-2035 at a CAGR of 7.80% to reach nearly USD 10.43 Billion by 2035.
Base Year
Historical Period
Forecast Period
The rising incidence of infectious diseases and the growing public awareness regarding the benefits of vaccination impacts the market demand significantly.
One of the major market trends is the increased focus on indigenous production of vaccines in the Asia Pacific region to facilitate a more reliable and stable supply of vaccines and reduce dependence on imported vaccines.
The market share is influenced by the rising economic development, increased national immunization programs, and the surge in the launch of advanced vaccines.
Compound Annual Growth Rate
7.8%
Value in USD Billion
2026-2035
*this image is indicative*
A vaccine provides immunity against various contagious diseases. It stimulates the production of antibodies to boost the immune system and prevent the risk or severity of symptoms. It is a crucial preventive and affordable medicine that eliminates the risk of hospitalization or prolonged illness from various diseases, such as hepatitis, influenzas, and Japanese Encephalitis, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The Asia Pacific vaccine market is characterized by the increasing prevalence of infectious disease outbreaks, especially in developing regions, such as India, Indonesia, and Thailand, among others, that surges the demand for efficient vaccines. The growing economic development in countries like China and India is leading to increased healthcare spending, which also impacts the global vaccine market. Moreover, governments are increasingly boosting vaccine purchase to ensure free vaccination of children to boost the overall quality of life of their citizens. For example, in August 2019, the Indian government announced the expansion of coverage of the rotavirus vaccine to end fatality and morbidity associated with the virus by 2023. Other factors that shape the market dynamics include heightened public awareness about the benefits of vaccination, strategic partnerships, and rising advancements in vaccine production technologies.
Increased Focus on Indigenous Production of Vaccines to Affect the Market Landscape Significantly
In January 2024, Indian Immunologicals Ltd (IIL), a subsidiary of the National Dairy Development Board and a leading human vaccine manufacturer in India, launched its vaccine Havisure, the first indigenously developed Hepatitis A vaccine, in Hyderabad (India). Havisure is a two-dose vaccine, with the first dose recommended for children above 12 months of age, and the second dose is administered at least 6 months after the first dose. The vaccine is reported to show comparable efficacy and safety as the international standards of Hepatitis A vaccine and has undergone rigorous clinical trials in 8 centers. This surge in the launch of indigenous vaccines is a significant growth driver of the market and is likely to improve self-reliance, affordability, and access to vaccines in the Asia Pacific region.
Increasing Availability of Vaccines to Meet Rising Asia Pacific Vaccine Market Demand
The robust growth of the healthcare sector in the region is propelling the market growth. The emergence of various start-ups and international companies in countries such as China and India is escalating the availability of critical vaccines, boosting the market share. In addition, the rising affordability and quality of vaccines owing to extensive indigenous manufacturing are significantly contributing to the growth of the market. The initiation of vaccination drives and campaigns by non-profit and humanitarian organizations is further increasing the accessibility and demand for vaccines in the region.
The market is witnessing several trends and developments to improve the current scenario in the Asia Pacific. Some of the notable trends are as follows:
“Asia Pacific Vaccine Market Report and Forecast 2026-2035” offers a detailed analysis of the market based on the following segments:
Market Breakup by Composition
Market Breakup by Type
Market Breakup by Age
Market Breakup by Indication
Market Breakup by Route of Administration
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Segmentation Based on Type is Anticipated to Witness Substantial Growth
The market segmentation based on the vaccine type includes recombinant and conjugate vaccines, inactivated vaccines, live attenuated vaccines, and toxoid vaccines, among others. The recombinant and conjugate vaccines segment represents a considerable share of the market due to their high efficacy and safety and their increased adoption in national immunization programs to prevent common and serious infections such as hepatitis B and meningococcal disease. On the other hand, inactivated vaccines are widely used for immunocompromised individuals due to their strong safety profile.
Based on the region, the market is segmented into China, Japan, India, ASEAN, and Australia, among others. In China, the market is poised to witness significant growth owing to increasing research and development (R&D) activities in the region. Moreover, the extensive production of vaccines, along with the presence of several leading companies is bolstering the market value. The introduction of various government initiatives to enhance capabilities in the biotechnology sector is augmenting the market growth. Furthermore, leading companies are increasingly investing in the country for the development of novel vaccines owing to the availability of cost-effective raw materials and highly skilled laborers, which is providing further impetus to the growth of the market.
The key features of the market report comprise patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, and strategic initiatives by the key players. The major companies in the market are as follows:
This global biotechnology company, Commonwealth Serum Laboratories (CSL) Limited, is headquartered in Melbourne, Australia, and is popular for its influenza and COVID-19 vaccines. CSL boasts robust R&D capabilities and an extensive distribution network in the Asia Pacific region.
Indian multinational biotechnology company Bharat Biotech International Limited stands as a leading manufacturer of high-quality vaccines and bio-therapeutics. It is known for developing Covaxin (COVID-19), Rotavac (rotavirus), and Typbar TCV (typhoid) vaccines, and significantly contributes to the Asia Pacific vaccine market share.
GSK plc (GlaxoSmithKline), a multinational pharmaceutical and biotechnology company, holds a strong portfolio that includes vaccines for diseases such as hepatitis, influenza, human papillomavirus (HPV), and meningitis, among others.
Pharmaceutical giant Pfizer Inc. has a prominent presence in the market due to its strong manufacturing capabilities and wide distribution network. Pfizer is known for its COVID-19 vaccine, Comirnaty, which it developed in collaboration with BioNTech.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include AstraZeneca PLC, Biological E. Limited, Serum Institute of India, Takeda, Merck & Co., Inc., Abbott, and Sanofi.
JE (Japanese Encephalitis) Vaccine Market
Upto 15% Off
USD
$2699 $2429
$4299 $3869
$5799 $4949
$6999 $5949
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Composition |
|
| Breakup by Type |
|
| Breakup by Age |
|
| Breakup by Indication |
|
| Breakup by Route of Administration |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share